Gene Therapy in Neurology: The Case for Optimism

Embark on an extraordinary journey into the world of gene therapy for neurological disorders with our cutting-edge white paper.

Uncover the remarkable breakthroughs in gene therapy that are transforming the landscape of inherited diseases, providing new hope to patients with limited therapeutic options. Explore the profound applications of gene therapy in treating prevalent neurological diseases like Parkinson’s, Alzheimer’s, and autism spectrum disorder, as well as rare conditions such as amyotrophic lateral sclerosis and spinal muscular atrophy.

Download our white paper to discover:

  • Gene therapy’s potential including uncovering strengths, limitations, and ethical considerations of novel techniques
  • Gene delivery’s impact on neurological disorders with autosomal recessive and dominance patterns gaining insights from preclinical studies and ongoing clinical trials

Learn more about our related services and resources:

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Neuroscience Expertise

Co design
Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting roomArticle

Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting room

Most CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.
Rethinking Clinical Operations: A Smarter, Faster Playbook for Trial SuccessWhite paper

Rethinking Clinical Operations: A Smarter, Faster Playbook for Trial Success

Learn how results-driven frameworks, integrated digital systems, and innovative strategies are transforming clinical operations.
Neurodegeneration clinical trial data analysis
Rare Neurological Disease Trials: Smarter Design with Natural History, External Controls, and Real-World EvidenceArticle

Rare Neurological Disease Trials: Smarter Design with Natural History, External Controls, and Real-World Evidence

Discover how natural history data, external controls, and RWE are reshaping rare neurological disease trials for smarter, regulatory-ready design.